IP

A Foundational IP Estate In The Human Microbiome Field

Vedanta has developed a key Intellectual Property (IP) portfolio in the human microbiome field. The portfolio includes fundamental patents covering compositions and therapeutic uses of products containing bacteria belonging to Clostridium clusters IV and XIVa, as well as spore-forming fractions obtained from stool samples. Bacteria within these clusters are among the most abundant colonizers of the human intestine and they play an important role in human health, including regulating immune responses. Our IP estate includes issued patents in the major pharmaceutical markets (US, Europe, and Japan), and these patents provide coverage through at least 2031, and their earliest priority dates are in 2010. This IP puts Vedanta in a unique leadership position in the microbiome field and allows us to support our internal programs as well as enable our partners to advance bacterial consortia therapeutics.

Vedanta’s European and U.S. Patents

Patent Title Applicant/Assignee Country Issue Date
EP2575835 Composition For Inducing Proliferation Or Accumulation Of Regulatory T Cells The University of Tokyo EP Oct 19, 2016
9,433,652 Composition For Inducing Proliferation Or Accumulation Of Regulatory T Cells The University of Tokyo US Sep 06, 2016
9,415,079 Composition For Inducing Proliferation Or Accumulation Of Regulatory T Cells The University of Tokyo US Aug 16, 2016
9,421,230 Composition For Inducing Proliferation Or Accumulation Of Regulatory T Cells The University of Tokyo US Aug 23, 2016
9,642,882 Composition For Inducing Proliferation Or Accumulation Of Regulatory T Cells The University of Tokyo US May 09, 2017
9,642,881 Human-Derived Bacteria That Induce Proliferation Or Accumulation Of Regulatory T Cells University of Tokyo; School Corporation, Azabu Veterinary Medicine Educational Institution US May 09, 2017
9,649,345 Human-Derived Bacteria That Induce Proliferation Or Accumulation Of Regulatory T Cells University of Tokyo; School Corporation, Azabu Veterinary Medicine Educational Institution US May 16, 2017
9,662,381 Composition for Inducing Proliferation Or Accumulation Of Regulatory T Cells The University of Tokyo US May 30, 2017